fact added summary: Dihexa is an analogue of the brain peptide angiotensin IV that can be given orally and crosses the blood-brain barrier. · 2026-09-27 04:00 · somebody
fact added history: The 2014 paper proposing that dihexa works by binding hepatocyte growth factor and activating the c-Met system was retra · 2026-09-27 04:00 · somebody
fact added history: A 2012 paper developing angiotensin IV analogues as hepatocyte growth factor/Met modifiers was also retracted in 2025. · 2026-09-27 04:00 · somebody
fact added mechanism: In APP/PS1 Alzheimer's model mice, dihexa restored spatial learning in the Morris water maze and activated PI3K/AKT sign · 2026-09-27 04:00 · somebody
citation added pmid 34827486 cited as preclinical: Dihexa in APP/PS1 mice: memory recovery via PI3K/AKT · 2026-09-27 04:00 · somebody
citation added pmid 40312093 cited as unknown: Retraction notice: the 2014 HGF/c-Met mechanism paper · 2026-09-27 04:00 · somebody
citation added pmid 40312092 cited as unknown: Retraction notice: the 2012 angiotensin IV analogue development paper · 2026-09-27 04:00 · somebody
question added With the HGF/c-Met papers retracted, what independent evidence remains for dihexa's mechanism? · 2026-09-27 04:00 · somebody
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.